Sort
82,697 grants matching “vaccine development”
Genetic and Structural Basis for Virus Neutralization of Paramyxoviruses
$1,835,755Vanderbilt University Medical Center · N01 · FY2025 · AI
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$1,835,675Mark Fredric Cotton · Stellenbosch University · U01 · FY2010 · AI
University of Cincinnati AIDS Clinical Trials Unit- UC ACTU
$1,835,084Carl J Fichtenbaum · University Of Cincinnati · U01 · FY2010 · AI
Directing the Immune System via Polymeric Combinations of Molecular Signals
$1,834,958Aaron P Esser-Kahn · University Of California-Irvine · DP2 · FY2013 · AI
Thymic vaccination: Manipulating the T cell repertoire
$1,834,795Dana-Farber Cancer Institute · R01 · FY2003 · AI
Pathogenesis and Vaccine Studies Of Simian Immunodeficiency Virus Infection Of Monkeys
$1,834,488Vanessa M. Hirsch · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
HIV VACCINES TRIAL UNITS
$1,833,511Fred Hutchinson Cancer Research Center · U01 · FY2000 · AI
Functional Biology Of T Cells
$1,833,378Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
A-Z Clinical Trials Unit
$1,833,108Edgar T Overton · University Of Alabama At Birmingham · UM1 · FY2021 · AI
Development of Technologies to Facilitate the Use of and Response to Vaccines
$1,833,080Dan Thomas Stinchcomb · Inviragen, Inc. · N01 · FY2010 · AI
Epidemiology and Ecology of Vibrio cholerae in Bangladesh
$1,832,493Richard Bradley Sack · Johns Hopkins University · R01 · FY2010 · AI
The Molecular Pathogenesis of Varicella Zoster Virus Infection
$1,832,432Maria Acena Nagel · University Of Colorado Denver · P01 · FY2018 · AG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,832,266Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
NEW LIVE VIRAL VECTORS AS CANDIDATE AIDS VACCINES
$1,832,252Emory University · P01 · FY2003 · AI
Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine
$1,831,862Mary E. Klotman · Duke University · P01 · FY2018 · AI
Consultation and Collaboration
$1,831,605Barry Graubard · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Centers for AIDS Research (CFAR)
$1,831,319Kent J. Weinhold · Duke University · P30 · FY2018 · AI
University of Rochester HIV/AIDS Clinical Trials Unit
$1,831,085Michael C Keefer · University Of Rochester · UM1 · FY2024 · AI
TASK A28: ADVANCED SMALL ANIMAL MODELS FOR THE TESTING OF CANDIDATE PREVENTIVE INTERVENTION AGAINST MYCOBACTERIUM TUBERCULOSIS
$1,830,908Angelo Izzo · Colorado State University · N01 · FY2019 · AI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)
$1,830,201Thomas Denny · Duke University · N01 · FY2023 · AI
Adjuvant Development Program
$1,830,015Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2011 · AI
Structure-Function Studies of the HIV-1 Envelope Glycoproteins and Development of a VLP-forming mRNA vaccine for HIV-1
$1,829,883Paolo Lusso · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Adjuvant Enhanced Antiviral Immunity
$1,829,840Jeff C Fairman · Juvaris Biotherapeutics, Inc. · U01 · FY2010 · AI
Toward a Universal Influenza Virus Vaccine
$1,829,781Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · AI
Immune Modulation/Hematopoietic Cell Transplantation
$1,829,756Robert Jon Soiffer · Dana-Farber Cancer Inst · U19 · FY2007 · AI